VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--Gentium S.p.A. (NASDAQ:GENT) (the “Company”) today reported that its lead product, Defibrotide, will be the topic of two presentations at the Seventh Annual EuroTIDES Conference on Oligonucleotide, RNAi and Peptide Technology for the Drug Development and Manufacturing Industry, a two day scientific symposium being held in Hamburg, Germany from December 4-6, 2006.
